The metabolic sensor GPR43 receptor plays a role in the control of Klebsiella pneumoniae infection in the lung

Izabela Galvão, Luciana P. Tavares, Renan O. Corrêa, José Luís Fachi, Vitor Melo Rocha, Marcela Rungue, Cristiana C. Garcia, Geovanni Cassali, Caroline M. Ferreira, Flaviano S. Martins, Sergio C. Oliveira, Charles R. Mackay, Mauro M. Teixeira, Marco Aurélio R. Vinolo, Angélica T. Vieira

Research output: Contribution to journalArticleResearchpeer-review

21 Citations (Scopus)


Pneumonia is one of the leading causes of death and mortality worldwide. The inflammatory responses that follow respiratory infections are protective leading to pathogen clearance but can also be deleterious if unregulated. The microbiota is known to be an important protective barrier against infections, mediating both direct inhibitory effects against the potential pathogen and also regulating the immune responses contributing to a proper clearance of the pathogen and return to homeostasis. GPR43 is one receptor for acetate, a microbiota metabolite shown to induce and to regulate important immune functions. Here, we addressed the role of GPR43 signaling during pulmonary bacterial infections. We have shown for the first time that the absence of GPR43 leads to increased susceptibility to Klebsiella pneumoniae infection, which was associated to both uncontrolled proliferation of bacteria and to increased inflammatory response. Mechanistically, we showed that GPR43 expression especially in neutrophils and alveolar macrophages is important for bacterial phagocytosis and killing. In addition, treatment with the GPR43 ligand, acetate, is protective during bacterial lung infection. This was associated to reduction in the number of bacteria in the airways and to the control of the inflammatory responses. Altogether, GPR43 plays an important role in the "gut-lung axis" as a sensor of the host gut microbiota activity through acetate binding promoting a proper immune response in the lungs.

Original languageEnglish
Article number142
Number of pages11
JournalFrontiers in Immunology
Publication statusPublished - 20 Feb 2018


  • GPR43
  • Inflammation
  • Lung infection
  • Microbiota
  • Pneumonia
  • Short-chain fatty acids

Cite this